68 related articles for article (PubMed ID: 15499755)
1. Cutaneous and ocular rosacea: Common and specific physiopathogenic mechanisms and study models.
Rodrigues-Braz D; Zhao M; Yesilirmak N; Aractingi S; Behar-Cohen F; Bourges JL
Mol Vis; 2021; 27():323-353. PubMed ID: 34035646
[TBL] [Abstract][Full Text] [Related]
2. Rosacea of the scalp: Results from a retrospective and prospective randomized controlled study.
Dall'Oglio F; Nasca MR; Lacarrubba F; Vitale P; Platania H; Nardone B; Micali G
J Eur Acad Dermatol Venereol; 2024 Feb; ():. PubMed ID: 38339858
[No Abstract] [Full Text] [Related]
3. Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure.
Hornig B; Arakawa N; Drexler H
Eur Heart J; 1998 Jul; 19 Suppl G():G48-53. PubMed ID: 9717056
[TBL] [Abstract][Full Text] [Related]
4. Swiss S1 guideline for the treatment of rosacea.
Anzengruber F; Czernielewski J; Conrad C; Feldmeyer L; Yawalkar N; Häusermann P; Cozzio A; Mainetti C; Goldblum D; Läuchli S; Imhof L; Brand C; Laffitte E; Navarini AA
J Eur Acad Dermatol Venereol; 2017 Nov; 31(11):1775-1791. PubMed ID: 28833645
[TBL] [Abstract][Full Text] [Related]
5. Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel.
Schaller M; Almeida LMC; Bewley A; Cribier B; Del Rosso J; Dlova NC; Gallo RL; Granstein RD; Kautz G; Mannis MJ; Micali G; Oon HH; Rajagopalan M; Steinhoff M; Tanghetti E; Thiboutot D; Troielli P; Webster G; Zierhut M; van Zuuren EJ; Tan J
Br J Dermatol; 2020 May; 182(5):1269-1276. PubMed ID: 31392722
[TBL] [Abstract][Full Text] [Related]
6. Treatment of ocular rosacea: comparative study of topical cyclosporine and oral doxycycline.
Arman A; Demirseren DD; Takmaz T
Int J Ophthalmol; 2015; 8(3):544-9. PubMed ID: 26086005
[TBL] [Abstract][Full Text] [Related]
7. Rosacea, reactive oxygen species, and azelaic Acid.
Jones DA
J Clin Aesthet Dermatol; 2009 Jan; 2(1):26-30. PubMed ID: 20967185
[TBL] [Abstract][Full Text] [Related]
8. Eyelid edema.
Sami MS; Soparkar CN; Patrinely JR; Tower RN
Semin Plast Surg; 2007 Feb; 21(1):24-31. PubMed ID: 20567653
[TBL] [Abstract][Full Text] [Related]
9. The subtypes of rosacea: implications for treatment.
Odom RB
Cutis; 2004 Jan; 73(1 Suppl):9-14. PubMed ID: 14959940
[TBL] [Abstract][Full Text] [Related]
10. Rosacea: II. Therapy.
Pelle MT; Crawford GH; James WD
J Am Acad Dermatol; 2004 Oct; 51(4):499-512; quiz 513-4. PubMed ID: 15389184
[TBL] [Abstract][Full Text] [Related]
11. Rosacea subtypes: a treatment algorithm.
Dahl MV
Cutis; 2004 Sep; 74(3 Suppl):21-7, 32-4. PubMed ID: 15499755
[TBL] [Abstract][Full Text] [Related]
12. The nosology of rosacea.
Odom R
Cutis; 2004 Sep; 74(3 Suppl):5-8, 32-4. PubMed ID: 15499751
[TBL] [Abstract][Full Text] [Related]
13. Rosacea: where are we now?
Bikowski JB; Goldman MP
J Drugs Dermatol; 2004; 3(3):251-61. PubMed ID: 15176158
[TBL] [Abstract][Full Text] [Related]
14. Rosacea: a review of current topical, systemic and light-based therapies.
Kennedy Carney C; Cantrell W; Elewski BE
G Ital Dermatol Venereol; 2009 Dec; 144(6):673-88. PubMed ID: 19907406
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
